ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

This 12-week study is testing a new drug called ENV-294 for adults with moderate-to-severe asthma that is not fully controlled despite using standard inhalers (a combination of a steroid and a long-acting bronchodilator). Researchers want to see if this new treatment can improve breathing and reduce asthma symptoms. **You may be eligible if...** - You are between 18 and 75 years old - You have had a doctor's diagnosis of moderate-to-severe asthma for at least 12 months - You have been on a stable dose of an inhaled steroid plus a long-acting bronchodilator for at least 2 months - Your breathing tests (lung function) show a specific pattern of reduced airflow that improves with a rescue inhaler **You may NOT be eligible if...** - You smoke or have smoked heavily in the past - You have other serious lung conditions (like COPD) - You have had a severe asthma attack requiring hospitalization recently - You are pregnant or breastfeeding - You have serious heart, liver, or immune system conditions Talk to your doctor to see if this trial is right for you.